References Early detection of diabetes among high risk groups http://www.doh.gov.uk/nsc/pdfs/diabetesnsc2.pdf UK National Screening Committee, Diabetes, Heart Disease and Stroke(DHDS)prevention pilot project, Project book version 3.0, winter 2003/4. http://www.nelh.nhs.uk/screening/diabetesproject Harris R et al, Screening Adults for Type 2 Diabetes Mellitus: Recommendations from the US preventive Services Task Force, Annals of Internal Medicine, Volume 138(3), 4 February 2003. World Health Organisation, Screening for Type 2 Diabetes, Report of a WHO and International Diabetes Federation meeting. WHO/NMH/MNC/03.1 http://www.who.int/ncd/dia/screening_mnc03.pdf Accessed 23 Dec 03 National Medical Health and Research Council Australia, Evidence Based Guidelines for Primary Prevention of Type 2 Diabetes and Case Detection & Diagnosis of Type 2 Diabetes. December 2001 at: http://www.nhmrc.gov.au/publications/synopses/cp86syn.htm Management of patients with impaired glucose tolerance Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. ‘Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin’ New England Journal of Medicine, Feb 7, 2002. 346. 6. 393-403. Pan X, Li G, Hu Y, Wang J, Yang W, An Z et al. ‘Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and diabetes study’ Diabetes Care 1997; 20: 537-44. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Finnish Diabetes prevention Study group. ‘Prevention of type 2 diabetes by changes in lifestyle among subjects with impaired glucose tolerance’ New England Journal of Medicine 2001; 344: 1343-1350. Implementing a diabetes register Hurwitz B, Goodman C, Yudkin J. 1993. ‘Prompting the clinical care of non-insulin dependent (type II) diabetic patients in an inner city area; one model of community care’ BMJ 306:624-30. Greenhaugh PM. 1994. Shared Care for Diabetes: A Systematic Review Occasional paper 67, London: The Royal College of General Practitioner Management of blood pressure UKPDS Group: ‘Tight blood pressure control and the risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38.’ BMJ 1998. 317. 703-13. HOT Study Group: ‘Effects of intensive blood pressure lowering and low dose aspitin in patinets with hypertension: principal results of the Hypertension Optimal Treatment randomised trial.’ Lancet 1998. 351. 1755-62. British Hypertension Society ‘Guidelines for hypertension management 2004 (BHS – IV) : Summary.’ BMJ 2004. 328. 634-40. ALLHAT Collaborative Research Group. ‘Major outcomes in high risk hypertensive patients randomised to ACE inhibitor or calcium channel blocker vs diuretic.’ JAMA 2002. 288. 2981-2997. Glucose control The Diabetes Control and Complications Trial Research Group. ‘The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus’ New England Journal of Medicine 1993; 329: 977-86. UKPDS Group. ‘Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)’ Lancet 1998; 352: 837-53 Guideline for the management of lipids in Diabetes NICE guidelines for hypertension: http://www.nice.org.uk/page.aspx?o=218469 BHS hypertension guidelines: http://www.hyp.ac.uk/bhs/Latest_BHS_management_Guidelines.htm Summary of product characteristics for Simvastatin: http://emc.medicines.org.uk/emc/industry/default.asp?page=displaydoc.asp&docume ntid=1201 Summary of product characteristics for atorvastatin: http://emc.medicines.org.uk/emc/industry/default.asp?page=displaydoc.asp&docume ntid=1201 Heart Protection Study Collaborative Group. MRC/BHF ‘Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomised placebo-controlled trial.’ Lancet 2002; 360: 7-22M Use of aspirin ‘Joint British recommendations on prevention of coronary heart disease in clinical practice’ Heart 1998; 80 (Suppl 2): S1-29 Hannson L et al. ‘Effect of intensive blood-pressure lowering and low dose aspirin in patients with hypertension; principal results of the hypertension optimal treatment (HOT) randomised trial’ Lancet 1998; 351; 1755-62. ‘Thrombosis Prevention Trial: randomised trial of low-intensity oral anticoagulation with warfarin and low dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk’ Lancet 1998; 351: 233-41 Foot examinations Litzelmann DK et al. ‘Reduction of lower extremity clinical abnormalities in patients with NIDDM’ Annals Intern Med 1993, 119:36-41. Pieber TR et al. ‘Evaluation of a structured teaching and treatment progtamme for type 2 diabetes in general practice in a rural area of Austria’ Diabetic Medicine 1995; 12: 349-54 Malone JM et al. ‘Prevention of amputation by diabetic education’ Am J Surgery 1989; 158:520-523 Eye screening Singer D et al. ‘Screening for diabetic retinopathy’ Ann Int Med 1992; 116: 660-71 The Diabetic Retinopathy Study Research Group. ‘Photocoagulation treatment of proliferative diabetic retinopathy. Clinincal application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8’ Ophthalmology 1981; 88: 583 Early Treatment Diabetic Retinopathy Study Research Group. ‘Photocoagulation for diabetic macular edema’ ETDRS study report No. 1. Arch Ophthalmol 1995; 103: 1796-1806 Screening for proteinuria Mogensen CE et al. ‘Prevention of diabetic renal disease with special reference to microalbuminuria’ Lancet 1995; 346: 1080-4. Lewis et al. ‘The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy’ N Engl J Med 1993; 329; 1456-62 Macrovascular disease Antiplatelet Trialists’ Collaboration. ‘Collaborative overview of randomised trials of antiplatelet therapy-1: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients’ BMJ 1994; 308: 81106 Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. ‘Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE artudt and MICRO-HOPE study’ Lancet 2000; 355: 253-9 Pyorala K et al. ‘Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study(4S)’ Diabetes Care 1997 20; 614-20 Zuanetti et al. ‘Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction; Data from the GISSI-3 study’ Circulation 1997; 96: 4239 Patient Education Fox, C and MacKinnon, M (1999). Vital Diabetes Class Publishing, London. MacKinnon, M (1998). Providing Diabetes Care in General Practice Class Publishing, London. Day, JL (1998). Living with Diabetes. Wiley & Sons Ltd, Chichester. Nutritional management British Diabetic Association (1992). ‘Dietary Recommendations for people with Diabetes: An update for the 1990s’ Diabetic Medicine, 9(2), 189 – 202. Diabetes UK (2004) Weight management: managing diabetes in primary care London: Diabetes UK available at www.diabetes.org.uk/catalogue/education.htm Ha TKK and Lean MJE (1998). ‘Technical Review: Recommendations for the nutritional management of patients with diabetes mellitus’ European Journal of Clinical Nutrition, 52, 467–481 Health Education Authority (1997). Helping People Change, Trainers Manual London: HEA. Monk A et al (1995). ‘Practical guidelines for medical nutrition therapy provided by dietitians for persons with NIDDM’ Journal of the American Dietetic Association, 95, 999 – 1006 Royal College of Physicians of London (1998). Clinical Management of overweight and obese patients London, Royal College of Physicians. Scottish Intercollegiate Guidelines Network (1996). Obesity in Scotland, Integrating Prevention with weight management SIGN Exercise ADA (1990). ‘Exercise and NIDDM (Technical Review)’ Diabetes Care, 137, 785– 789 ADA (1994). ‘Exercise in individuals with IDDM (Technical Review)’ Diabetes Care,17,924–937 ADA (1998). ‘Diabetes Mellitus and Exercise’ Diabetes Care, 21(S1), 540– 44 Physical Activity Task Force (1995). More people, more active, more often: Physical Activity in England, a consultation paper. Dept of Health. SIGN (1996) Obesity in Scotland, Integrating prevention with weight management SIGN Achieving lifestyle change Dunn C and Rollnick S (2003) Lifestyle Change London: Elsevier Ltd. Health Education Authority (1997). Helping people change, Trainers Manual London: HEA Hunt P and Hillsdon M (1996). Changing eating and exercise behaviour Oxford: Blackwell Science. Prochaska JO and Di Clemente CC (1986). ‘Towards a comprehensive model of change’ in: Miller, WR, and Heather N, (eds). Treating addictive behaviour New York, Plenum. Diabetes and psychological distress Type 1 Diabetes: the diagnosis and management of Type 1 diabetes in adults. Clinical Guideline 15. NICE, London. July 2004 http://www.nice.org.uk/pdf/CG015_fullguideline_adults_main_section.pdf International Diabetes Federation (2005) Global Guideline for Type 2 Diabetes: Psychological Care 19-21. Depression: Management of depression in Primary and Secondary Care. Clinical Guideline 23. NICE, London 2004. www.nice.org.uk/pdf/CG023NICEguideline.pdf BMA and NHSEmployers. Revisions to the GMS Contract 2006/7: Delivering investment in General Practice. March 2006. http://www.ehiprimarycare.com/tc_domainsBin/Document_Library0282/2006_Revisio ns_to_GMS_contract_-_full.pdf Zigmond, A.S. & Snaith, R.P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 63-70. www.nfer-nelson.co.uk/catalogue/catalogue_detail.asp?catid=98&id=1125 Kroenke et al. Journal of General Internal Medicine 16 606-613 2001 www.depressionprimarycare.org/clinicians/toolkits/materials/forms/phq9/questionnaire/ Arnau et al Health Psychology 20 (2) 112-119 2001. Anxiety: Management of anxiety in adults in Primary and Secondary Care. Clinical Guideline 22. NICE, London December 2004. www.nice.org.uk/pdf/CG022NICEguideline.pdf Draft Sheffield Guidelines for Primary Care Management of Mental Health Problems, 2nd Edition, 2004 Bradley,C. & Gamsu, D.S. (1994). Guideline for encouraging psychological wellbeing. Report for the World Health Organisation and St. Vincent Declaration Action Programme for Diabetes. Diabetic Medicine, 11, 510-16. Hurrell, E. & Leahy, M Guidelines for Assessing Depression in people with Coronary Heart Disease. CIRC team, Sheffield 2001. Shillitoe R (1994) Counselling people with diabetes BPS Books. Self help references Anxiety Kennerley, H. (1997). Overcoming Anxiety: a self-help guide using cognitive behaviour techniques. London: Robinson. Padesky, C. & Greenburger, D. (1995). Mind over mood: changing the way you feel by changing the way you think. Guildford, Guildford Press. Silove, D. (1997). Overcoming Panic: a self-help guide using cognitive behaviour techniques. London: Robinson. Chronic health problems – heart disease & diabetes Holman, H., Sobel, D., Laurent, D., Gonzalez, V., Minor, M., & Lorig, K. (2000). Living a healthy life with chronic conditions: Self-management of heart disease, arthritis, diabetes, asthma, bronchitis, emphysema and others. USA, Bull Publishing Co. Depression Burns, D.D. (2000). The feeling good handbook. London, Penguin Books Ltd. Gilbert, P. (2000). Overcoming Depression: a self-help guide using cognitive behaviour techniques. London: Robinson. Padesky, C. & Greenburger, D. (1995). Mind over mood: changing the way you feel by changing the way you think. Guildford, Guildford Press. Rowe, D. (2003). Depression: The way out of your prison. London: BrunnerRoutledge.